Tags: SCIO is critical for accelerating approval and significantly reducing the costs of drug and medical device development.
One of the major challenges facing this industry is the rising cost of clinical trials. Thus, it is crucial to ensure that trials are significantly more efficient and cost-effective with the involvement of strategy at the time of pre-IND/IND and IDE submission. It is imperative to ensure that the clinical trial attrition is reduced.
With high costs associated with the later phase of development, developing Clinical Proof of Concept and early stage trials are extremely important. Strategic consulting that specializes in early stage development is essential to create study design and reach proof of concept in efficient time frames thereby reducing costs up to 30%.
BBCR Consulting adopts the SCIO process (Strategic Clinical Innovation Organization) and operates on the fundamental principle that strategy and design are keys for the success of drug and medical device development.
To learn more about how BBCR can help, we invite you to reach out today by filling out the form below.
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.